Shawn Owen

14PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMolecular targetsGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 13, 2026
Computer-guided dosing of multi-specific T-cell engagers.

|Jan 22, 2025
Modular Synthesis of Anti-HER2 Dual-Drug Antibody-Drug Conjugates Demonstrating Improved Toxicity.

Christine S Nervig, Megan Rice, Marcello Marelli

|Jun 27, 2024
Surface-Available HER2 Levels Alone Are Not Indicative of Cell Response to HER2-Targeted Antibody-Drug Conjugate Therapies.

Molly Major, Christine S Nervig, Annette Gerland

|Nov 30, 2023
Therapeutic Fusion Proteins.

Morgan C Marsh, Shawn C Owen

|Nov 17, 2022
Complementation Dependent Enzyme Prodrug Therapy Enables Targeted Activation of Prodrug on HER2-Positive Cancer Cells.

Christine S Nervig, Samuel T Hatch, Shawn C Owen

|Jul 01, 2022
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies.

Sun Jin Kim, Zhong Yao, Morgan C Marsh

Pageof 3

Frequent Collaborators

2 joint publications

Christine S Nervig

2 joint publications

Igor Stagljar

1 joint publications

Aditya V Gandhi

1 joint publications

Boi Hoa San